Article
One-step, rapid, nanoparticle-based biosensor platform for the simultaneous identification of hepatitis B virus and hepatitis C virus in clinical applications.
BMC microbiology - 6 Nov 2024
Chen Xu, Shi Yuanfang, Zhao Qi, Wang Yu, Yang Xinggui, Tan Yan, Wang Yi, Dong Shilei, Xiao Zhenghua
Abstract excerpt
OBJECTIVES: Viral hepatitis caused by hepatitis B virus (HBV) and hepatitis C virus (HCV) infections remain a major global public health challenge, particularly in low- and middle-income countries. It is crucial to utilize a pointof-care (POC) testing platform that is sensitive, specific, rapid, and user-friendly for screening and diagnosis of the two infections. Here, a novel molecular diagnostic assay,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
